PAFP Provider Feedback Trial in Nepal
Applying Behavioural Insights to Improve Take up of Post-abortion Family Planning: In-depth Study in Nepal
1 other identifier
interventional
12,000
1 country
36
Brief Summary
A six-month RCT conducted within 36 health centres throughout urban and rural Nepal. The purpose of the RCT is to test the effectiveness of a peer comparison intervention at increasing uptake of long-acting reversible contraceptives (LARCs) as a percentage of PAFP uptake among clients who receive a safe abortion at a Marie Stopes International Nepal. The total sample size will be \~12,000 safe abortion clients. The primary outcome of interest is LARCs among safe abortion clients at Marie Stopes Centres in Nepal. The secondary outcome is to evaluate the impact of behaviorally designed intervention on the service providers' engagement in discussing measures to increase PAFP LARC uptake among women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2016
Shorter than P25 for not_applicable
36 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 1, 2017
CompletedFirst Posted
Study publicly available on registry
March 6, 2017
CompletedMay 9, 2017
May 1, 2017
7 months
March 1, 2017
May 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Long term reversible contraceptives uptake as a percentage of post-abortion family planning uptake among safe abortion clients within 2 weeks
The study aims to observe a minimum 4% difference in PAFP LARC rates at two weeks post-abortion between intervention and control participants.
2 weeks post-abortion
Secondary Outcomes (1)
Types of family planning method used after safe abortion procedure
2 weeks post abortion
Study Arms (2)
Intervention (receive data updates)
EXPERIMENTALIntervention clinics will receive a monthly poster that centres will receive which informs service providers of the PAFP LARC uptake rate at their centre. This is a step-wedged randomised controlled trial where all the clinics will eventually receive an intervention by the end of the study.
Control (no data updates)
NO INTERVENTIONService providers at these clinics will not receive monthly information on PAFP LARC rates.
Interventions
Providers will receive visual and text feedback on their centre's PAFP uptake rates as they compare to the uptake rates of other centres. The feedback will be delivered monthly in a physical paper format.
Eligibility Criteria
You may qualify if:
- All women over the age of 18 who receive safe abortion services at the 36 centres are eligible to participate in the study. Women will be opted in to the study.
You may not qualify if:
- Women \<18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Marie Stopes Internationallead
- Ideas42collaborator
Study Sites (36)
Marie Stopes Chuchchepati
Kathmandu, Bagati, Nepal
Marie Stopes Gongabu
Kathmandu, Bagati, Nepal
Marie Stopes Putalisadak
Kathmandu, Bagmati, Nepal
Marie Stopes Satdobato
Kathmandu, Bagmati, Nepal
Marie Stopes Banepa
Kavre, Bagmati, Nepal
Marie Stopes Nuwakot
Nuwakot, Bagmati, Nepal
Marie Stopes Kohalpur
Bānke, Bheri, Nepal
Marie Stopes Surkhet
Surkhet, Bheri, Nepal
Marie Stopes Parbat
Parbat, Dhaulagiri, Nepal
Marie Stopes Gorkha
Gorkha, Gandaki, Nepal
Marie Stopes Pokhara
Kāski̇̄, Gandaki, Nepal
Marie Stopes Dumre
Tanahun, Gandaki, Nepal
Marie Stopes Janakpur
Dhanusa, Janakpur, Nepal
Marie Stopes Bardibas
Mahottari, Janakpur, Nepal
Marie Stopes Lalbandi
Sarlahi, Janakpur, Nepal
Marie Stopes Jumla
Jumla, Karnali, Nepal
Marie Stopes Hile
Dhankutā, Koshi, Nepal
Marie Stopes Biratnagar
Morang, Koshi, Nepal
Marie Stopes Itahari
Sunsari, Koshi, Nepal
Marie stopes Arghakhachi
Arghakhachi, Lumbini, Nepal
Marie Stopes Gulmi
Gulmi, Lumbini, Nepal
Marie Stopes Chandrauta
Kapilbastu, Lumbini, Nepal
Marie Stopes Taulihawa
Kapilbastu, Lumbini, Nepal
Marie Stopes Bhairahawa
Lumbini, Lumbini, Nepal
Marie Stopes Butwal
Lumbini, Lumbini, Nepal
Marie Stopes Bardghat
Nawalparasi, Lumbini, Nepal
Marie Stopes Dadheldhura
Dadheldhura, Mahakali, Nepal
Marie Stopes Ilam
Ilām, Mechi, Nepal
Marie Stopes Birtamod
Jhapa, Mechi, Nepal
Marie Stopes Narayanghat
Chitwan, Narayani, Nepal
Marie Stopes Hetauda
Makwanpur, Narayani, Nepal
Marie Stopes Birgunj
Parsa, Narayani, Nepal
Marie Stopes Dang
Dāng, Rapti, Nepal
Marie Stopes Pyuthan
Pyūthān, Rapti, Nepal
Marie Stopes Lahan
Siraha, Sagarmatha, Nepal
Marie Stopes Attariya clinic
Kailāli̇̄, Seti, Nepal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saugato Datta
Ideas42
- PRINCIPAL INVESTIGATOR
Karina Lorenzana
Ideas42
- PRINCIPAL INVESTIGATOR
Pragya Gartoulla, PhD
Marie Stopes Nepal
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Scientific Advisor
Study Record Dates
First Submitted
March 1, 2017
First Posted
March 6, 2017
Study Start
July 1, 2016
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
May 9, 2017
Record last verified: 2017-05